Menu Content/Inhalt
The JCA Mauvernay Award / Japan

In 2009, Debiopharm Group and the Japanese Cancer Association (JCA) honored Dr Toshikazu Ushijima, National Cancer Center Research Institute, Tokyo with the JCA Mauvernay Award for outstanding work in oncology.

The JCA Mauvernay Award was granted on October 3, 2009,  at the occasion of the 68th Annual Meeting of the Japanese Cancer Association held from October 1 until October 3 in Yokohama, Japan. Professor Setsuo Hirohashi, President of the JCA and Dr Rolland-Yves Mauvernay, Founder and President of Debiopharm Group presented the award.

The Award, funded by Debiopharm and organised by the JCA, aims to recognise cutting-edge oncology research in both the fundamental and the clinical aspects and to encourage Japanese researchers to make their work available to other parts of the world. Potential Candidates must be researchers and members of the JCA who have been recommended by the councillors of the JCA and who have achieved excellent results in the fields of either basic or clinical research in oncology. The JCA counts about 17,000 members, all from universities, governmental and private research organisations throughout Japan.

Each year, the Award Committee selects nominee(s) for the JCA-Mauvernay Award from fundamental cancer research and/or clinical cancer research.

Nominees:

2009

  • Dr Toshikazu Ushijima, National Cancer Center Research Institute, Tokyo

The Japanese Cancer Association and Debiopharm Group present the JCA-Mauvernay Award to Dr Ushijima for his oncology research

2008

  • Professor Hidenori Ichijo, Graduate School of Pharmaceutical Sciences, University of Tokyo
  • Professor Hiroyuki Mano, Functional Genomics Division at Jichi Medical University

Japanese Cancer Association and Debiopharm Honour Japanese Research - Professors Ichijo and Mano receive 2008 JCA-Mauvernay Award

2007 

  • Professor Minoru Toyota, First Department of Internal Medicine, Sapporo Medical University,
  • Professor Keiichi Nakayama, Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University

Japanese Scientists Receive JCA-Mauvernay Award 2007

2006

  • Professor Hatakeyama, Institute for Genetic Medecine, Hokkaido University
  • Professor Inazawa, Medical Research Institute, Tokyo Medical & Dental University
The Japanese Cancer Association and Debiopharm honour Professors Masanori Hatakeyama and Johji Inazawa with the 2006 JCA-Mauvernay Award

2005
  • Dr Mitsudomi, Aichi Cancer Center Hospital
  • Dr Ishikawa, Graduate School of Biostudies, Kyoto University
The Japanese Cancer Association (JCA) and Debiopharm present the Inaugural 2005 JCA-Mauvernay-Award in Japan